The effect of increased bilirubin level on the risk of cerebral palsy

Marta Sternal; Barbara Kwiatkowska; Krzysztof Borysławski; Agnieszka Tomaszewska

doi:10.2478/anre-2020-0013

Authors

Marta Sternal Department of Anthropology, Wroclaw University of Environmental and Life Sciences, Poland
Barbara Kwiatkowska Department of Anthropology, Wroclaw University of Environmental and Life Sciences, Poland
Krzysztof Borysławski Department of Anthropology, Wroclaw University of Environmental and Life Sciences, Poland
Agnieszka Tomaszewska Department of Anthropology, Wroclaw University of Environmental and Life Sciences, Poland

DOI:

https://doi.org/10.2478/anre-2020-0013

Keywords:

cerebral palsy, bilirubin, type of birth

Abstract

Increased bilirubin level in blood is mentioned among the potential factors with causal effect on cerebral palsy. The objective of the study was the analysis of its effect on the risk of cerebral palsy, considering all the significant risk factors as well as division into singleton, twin, term and preterm births. The research included a group of 278 children with cerebral palsy from selected educational-therapeutic institutions in Poland. The control group consisted of data from medical records of 435 neonates born in God’s Mercy Hospital in Limanowa, Poland. The analysis considered socio-economic factors, factors associated with pregnancy and parturition as well as accompanying disturbances and diseases of the children. Constructed models of logistic regression were used in statistcal analysis. The results were presented as the odds ratio (OR) with 95% confidence interval (CI). Testing the effect of increased bilirubin level in blood showed that the increased level of bilirubin is a significant predictor of CP in the categories of all children (OR 2.52, 95% CI: 1.47–4.33), children from singleton births (OR 2.66, 95% CI: 1.55–4.57), term births (OR 2.18, 95% CI: 1.24–3.84), term singleton births (OR 2.35, 95% CI: 1.31–4.21), preterm births (4.87, 95% CI: 1.56–15.21) and preterm singleton births (OR 3.62, 95% CI: 1.24–10.58). Increased bilirubin level is an independent risk factor in the development of cerebral palsy.

Downloads

Download data is not yet available.

References

Blair E, Stanley F. 2002. Causal pathways to cerebral palsy. Curr Paediatr 12(3):179–85.

Jacobsson B, Ladfors L, Milson I. 2004. Advanced Maternal Age and Adverse Perinatal Outcome. Am Coll Obsteric Gynecol 104(4):727–32.

Jaskulski T, Zgorzalewicz B. 1993. Zastosowanie komputerowego rejestru do badań nad epidemiologią mózgowego porażenia dziecięcego. Neurol Dziec 2(3):13–9.

Johnson A, Catterson J. 1988. Trends in birth prevalence of cerebral palsy. Arch Dis Child 63(3):340.

Kiely J, Paneth N, Stein Z, Susser M. 1981. Cerebral palsy and newborn care. I:Secular trends in cerebral palsy. Dev Med Child Neurol 23:533–8.

Koman AL, Smith PB, Shilt JS. 2004. Cerebral palsy. Lancet 363:1619–31.

Korzeniewski S. 2006. The Descriptive Epidemiology of Cerebral Palsy. Clin Perinatol 33:251–67.

Kwolek A, Majka M, Pabis M. 2001. Rehabilitacja dzieci z porażeniem mózgowym – problemy, aktualne kierunki. Ortop Traumatol Rehab 3(4):499–507.

Milewska A, Mileańczuk-Lubecka BA, Kochanowski J, Werner B. 2011. Analiza czynników ryzyka mózgowego porażenia dziecięcego. Nowa Pediata 4:79–84.

Nuthall G, Seear M, Lepawsky M, Wensley D, Skippen P, Hukin J. 2000. Hyperbaric Oxygen Therapy for Cerebral Palsy:Two complications of Treatment. Pediatrics 106(6):1–3.

Okperi BO. 2013. Neonatal jaundice and birth asphyxia as major causes of cerebral palsy in Nigeria:are doctors’ wrong beliefs and practices part of the problem? Int J Med Biomed Res 2(3):226–30.

Öztürk A, Demirici F, Yavuz T, Yildiz S, Degirmenci Y, Döşoglu M, Avşar Y. 2007. Ante-natal and delivery risk factors and prevalence of cerebral palsy in Duzce (Turkey). Brain Dev 29(1):39–42.

Platt MJ, Pharoah POD. 1995. Epidemiology of cerebral palsy. Curr Paediatr 5:151–55.

Polani PE. 1958. Prematurity and “Cerebral Palsy”. Br Med J 2:1497–9.

Reid S, Carlin J, Reddihough D. 2011. Rates of cerebral palsy in Victoria, Australia, 1970 to 2004:has there been a change? Dev Med Child Neurol 53:907–12.

Robertson ChMT, Watt M, Yasui Y. 2007. Changes in the Prevalence of cerebral Palsy for Children Born Very Prematurely Within a Population-Based Program Over 30 Years. JAMA- J Am Med Assoc 297(24):2733–40.

Rosenbaum P. 2003. Cerebral palsy: what parents and doctors want to know? Br Med J 326:970–4.

Śmiechura M, Makowska-Piontek A, Makowski P. 2010. Wpływ podwyższonego poziomu bilirubiny jako izolowanego czynnika ryzyka na stan słuchu niemowląt. Prz Lek 67(3):178–80.

Soleimani F, Vameghi R, Biglarian A. 2013. Antenatal and Intrapartum Risk Factors of Cerebral Palsy in Term and Near-term Newborns. Arch Iran Med 16(4):213–6.

Sternal M, Kwiatkowska B, Borysławski K, Tomaszewska A. 2020. Paternal age and the risk of cerebral palsy. Anthr Rev 83(1):31–41.

Thorngren-Jerneck K, Herbst A. 2006. Perinatal Factors Associated with Cerebral Palsy in Children Born in Sweden. Obstet Gynecol 108(6):1499–505.

Wasiluk A, Polewko A, Ozimirski A. 2012. Współczesna diagnostyka i leczenie żół-taczek u noworodków i niemowląt. Diagn Lab 48(4):405–11.

Wu YW, Croen L, Shah S, Newman T, Najjar D. 2010. Cerebral palsy in a Term Population:Risk Factors and Neuroimaging Finding. Pediatrics 118(2):690–7.

Zgorzalewicz B, Mieszczanek T, Zgorzalewicz M. 2001. Epidemiologia opisowa mózgowego porażenia dziecięcego. Ortop Traumatol Rehab 3(4):467–71.